New Measures have simplified the regime for private funds in China and enhanced the CSRC's authority. But key issues are left unresolved and confusion over the tripartite regulatory system remains a problem
This week Hilton sold the iconic New York hotel for US$1.95 billion to a Chinese insurance company, the NDRC's anti-foreigner bias was discussed, a biodiesel dispute put the market in the spotlight and winners celebrated the 2014 CLP Awards
The State Council has released a Decision improving access in the Shanghai FTZ, the SPC has issued an Interpretation on environmental public interest lawsuits and the CIRC has produced a Circular clarifying when insurance companies can issue preference shares
Getting a decision in your favour is only part of the battle in China. Enforcement is often delayed or blocked completely, with businesses having to settle for reduced sums. Here are five tips to make sure you can get your money
Getting a decision in your favour is only part of the battle in China. Enforcement is often delayed or blocked completely, with businesses having to settle for reduced sums. Here are five tips to make sure you can get your money
This week GlaxoSmithKline was handed the largest ever corporate fine in China, Apple waited on regulatory approval to sell its latest iPhone and a checklist for foreign companies doing business in China was discussed
The CBRC has set capital requirements for foreign-funded banks and the CIRC has issued rules for property insurance companies to establish an assumption reinsurance management system